Position in VYGR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$102,095
-$276,041 QoQ
Shares Held
29,170
-70.2% QoQ
Ownership
0.047%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#67
of 135 holders
Holding Since
Dec 2020
17 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VYGR Over Time
Shares Held
Position Value (USD)
Derivatives in VYGR
reported options exposure · as of Jun 30, 2026CallValue
$134,750
CallShares
38,500
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026JANE STREET GROUP, LLC holds $1,372,861,470 across 292 Biotechnology names. VYGR ranks #199 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BBIO |
BridgeBio Pharma, Inc.
|
2,934,193 | $218,538,693 | |
| 2 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
191,541 | $102,847,939 | |
| 3 | AXSM |
Axsome Therapeutics, Inc.
|
403,995 | $98,885,855 | |
| 4 | TGTX |
Tg Therapeutics, Inc.
|
1,752,646 | $96,290,370 | |
| 5 | EXEL |
Exelixis, Inc.
|
1,402,438 | $76,306,651 | |
| 6 | QURE |
uniQure N.V.
|
1,610,483 | $74,178,846 | |
| 7 | HALO |
Halozyme Therapeutics, Inc.
|
694,684 | $54,372,915 | |
| 8 | TVTX |
Travere Therapeutics, Inc.
|
938,699 | $53,327,489 |
All Filings in VYGR
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $102,095 | 29,170 | Shares | Defined | 2026-08-14 | |
| 2026-06-30 | $134,750 | 38,500 | Call | Defined | 2026-08-14 | |
| 2026-03-31 | $378,136 | 97,963 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $588,504 | 149,747 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $749,496 | 160,492 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $86,594 | 27,844 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $48,857 | 14,455 | Shares | Defined | 2025-05-19 | |
| 2024-12-31 | $430,233 | 75,879 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $495,214 | 84,652 | Shares | Defined | 2024-11-15 | |
| 2024-06-30 | $1,524,992 | 192,793 | Shares | Defined | 2024-08-15 | |
| 2024-03-31 | $386,541 | 41,519 | Shares | Defined | 2024-05-16 | |
| 2023-06-30 | $522,784 | 45,658 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $1,333,182 | 172,916 | Shares | Defined | 2023-05-16 | |
| 2022-12-31 | $152,920 | 25,069 | Shares | Defined | 2023-02-15 | |
| 2022-06-30 | $101,202 | 17,124 | Shares | Defined | 2022-08-16 | |
| 2022-03-31 | $275,844 | 36,200 | Call | Defined | 2022-05-17 | |
| 2022-03-31 | $185,166 | 24,300 | Put | Defined | 2022-05-17 | |
| 2022-03-31 | $617,753 | 81,070 | Shares | Defined | 2022-05-17 | |
| 2021-12-31 | $37,091 | 13,687 | Shares | Defined | 2022-02-15 | |
| 2020-12-31 | $125,804 | 17,595 | Shares | Defined | 2021-02-17 | |
| No filing history on record for this holder in this stock. | ||||||